SHADRACH SMITH: Open Payments
NPI 1093770299 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,335 in 114 payments from 29 companies in 2025. Trend: 2023 $2,158 · 2024 $2,618 · 2025 $13,335
Speaker / faculty: $10,800Food & beverage: $2,535
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 19 | $11,021 |
| Novo Nordisk Inc | 15 | $532 |
| Astellas Pharma US Inc | 6 | $197 |
| PFIZER INC. | 10 | $162 |
| GlaxoSmithKline, LLC. | 5 | $155 |
| AstraZeneca Pharmaceuticals LP | 6 | $155 |
| Amgen Inc. | 10 | $155 |
| SHIELD THERAPEUTICS INC | 3 | $154 |
| ABBVIE INC. | 7 | $134 |
| Abbott Laboratories | 4 | $83 |
Products named: ZEPBOUND, Wegovy, Ozempic, Veozah, ACCRUFER, MOUNJARO, VRAYLAR, AIRSUPRA.
Industry payments across KS — which companies pay providers there.
